Wernli Karen J, Ray Roberta M, Gao Dao Li, De Roos Anneclaire J, Checkoway Harvey, Thomas David B
Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Cancer Causes Control. 2006 Sep;17(7):949-55. doi: 10.1007/s10552-006-0034-6.
Menstrual, reproductive and contraceptive factors have been associated with risk of endometrial cancer in populations where the incidence of this tumor is high. To investigate associations between these factors in a low-risk population with a low prevalence of hormone replacement therapy, we conducted a cohort study among 267,400 women employed in the textile industry in Shanghai, China. Menstrual, reproductive and other factors were ascertained at baseline in 1989-1991, and women were followed for incident endometrial cancer through 31 December 1998 (n = 206). Cox proportional hazards modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Risk of endometrial cancer decreased with increasing age at menarche (p-trend = 0.004). Among menopausal women, risk increased with age at menopause and increasing years of menstruation. Compared to women with one live birth, risk was increased in relation to nulliparity (Hazard ratio = 3.95, 95% CI 1.43-10.86). Risk was decreased with increasing age at first live birth (p-trend = 0.03). There was a decreased risk associated with ever use of an intrauterine device (HR = 0.56, 95% CI 0.35-0.88) and use of oral contraceptives for > or =2 years (HR = 0.50, 95% CI 0.23-1.07). This prospective study confirms findings from previous case-control studies relating menstrual, reproductive, and contraceptive factors and endometrial carcinoma.
在子宫内膜癌发病率较高的人群中,月经、生殖和避孕因素与子宫内膜癌风险相关。为了在激素替代疗法使用率较低的低风险人群中研究这些因素之间的关联,我们在中国上海的267,400名纺织行业从业女性中开展了一项队列研究。月经、生殖和其他因素于1989 - 1991年在基线时确定,对女性进行随访直至1998年12月31日,以观察子宫内膜癌发病情况(n = 206)。采用Cox比例风险模型估计风险比(HR)和95%置信区间(CI)。子宫内膜癌风险随着初潮年龄增加而降低(p趋势 = 0.004)。在绝经女性中,风险随着绝经年龄增加和月经年限增加而升高。与有一次活产的女性相比,未生育女性的风险增加(风险比 = 3.95,95% CI 1.43 - 10.86)。风险随着首次活产年龄增加而降低(p趋势 = 0.03)。曾经使用宫内节育器(HR = 0.56,95% CI 0.35 - 0.88)以及使用口服避孕药≥2年(HR = 0.50,95% CI 0.23 - 1.07)与风险降低相关。这项前瞻性研究证实了既往病例对照研究中关于月经、生殖和避孕因素与子宫内膜癌的研究结果。